These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 32543142)
1. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance]. Jing CX; Feng Y; Cao X; Xu CG Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma. Jing C; Zheng Y; Feng Y; Cao X; Xu C Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776 [TBL] [Abstract][Full Text] [Related]
3. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance]. Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417 [TBL] [Abstract][Full Text] [Related]
5. Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma. He J; Xi Y; Gao N; Xu E; Xie L; Chang J; Liu J J BUON; 2019; 24(4):1679-1685. PubMed ID: 31646825 [TBL] [Abstract][Full Text] [Related]
6. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases. Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697 [TBL] [Abstract][Full Text] [Related]
7. PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. Zhang X; Han Y; Nie Y; Jiang Y; Sui X; Ge X; Liu F; Zhang Y; Wang X J Mol Med (Berl); 2023 May; 101(5):595-606. PubMed ID: 37126184 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance of miRNA-223 targeting SOX11 in mantle cell lymphoma]. Zhang Q; Zhang WT; Wu SS; Yuan JJ; Tian L; Liu YY; Zuo WL; Song YP; Zhou KS Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):579-583. PubMed ID: 30122018 [No Abstract] [Full Text] [Related]
9. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma. He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407 [TBL] [Abstract][Full Text] [Related]
10. Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma. Chuang WY; Chang H; Shih LY; Lin TC; Yeh CJ; Ueng SH; Kuo MC; Kao HW; Liu H; Chang ST; Lee CL; Huang KP; Wang TH; Wan YL; Yu JS; Hsueh C; Chuang SS Virchows Arch; 2024 Aug; 485(2):323-334. PubMed ID: 38733379 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma. Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928 [TBL] [Abstract][Full Text] [Related]
13. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma? Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893 [TBL] [Abstract][Full Text] [Related]
14. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression. Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B Sci Rep; 2013; 3():1400. PubMed ID: 23466598 [TBL] [Abstract][Full Text] [Related]
15. [Expression of myocyte enhancer factor 2B in mantle cell lymphoma and its clinical significance]. Liu F; Liu Q; Guo N; Zhang GM; Deng YF; Hu WW; Rao HL Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):40-46. PubMed ID: 31914533 [No Abstract] [Full Text] [Related]
16. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma. Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas. Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898 [TBL] [Abstract][Full Text] [Related]
18. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11. Wu B; Li J; Wang H; Wu Q; Liu H Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593 [TBL] [Abstract][Full Text] [Related]
19. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Kuo PY; Leshchenko VV; Fazzari MJ; Perumal D; Gellen T; He T; Iqbal J; Baumgartner-Wennerholm S; Nygren L; Zhang F; Zhang W; Suh KS; Goy A; Yang DT; Chan WC; Kahl BS; Verma AK; Gascoyne RD; Kimby E; Sander B; Ye BH; Melnick AM; Parekh S Oncogene; 2015 Mar; 34(10):1231-40. PubMed ID: 24681958 [TBL] [Abstract][Full Text] [Related]
20. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma. Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]